Therapeutic Drug Monitoring (TDM) of Infliximab test is performed to monitor levels of Infliximab, a biologic drug used to treat autoimmune diseases, such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, and psoriasis. The goal of this monitoring is to ensure that blood levels of the drug are at optimal levels, allowing for the best therapeutic effect while minimizing side effects.